Investor Relations

A leadership story in the field of advanced cell therapy

Investor Relations

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Jun 18, 2019
Document Date
Jun 15, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Vericel Corporation
Issuer
Vericel Corp
Filer
Halpin Michael

Day High:
Day Low:
Volume:
on
Copyright West LLC. Minimum 15 minutes delayed.